Francesco Foti is an accomplished Director of Operations at AbbVie, specializing in the Eyecare division, where he leverages over 18 years of experience in the pharmaceutical industry. With a PhD in Supramolecular Chemistry from Pavia University, Francesco has a robust foundation in organic synthesis and...
Francesco Foti is an accomplished Director of Operations at AbbVie, specializing in the Eyecare division, where he leverages over 18 years of experience in the pharmaceutical industry. With a PhD in Supramolecular Chemistry from Pavia University, Francesco has a robust foundation in organic synthesis and analytical methods characterization, which he has applied throughout his career. His journey began in Chemical Development, where he honed his skills in laboratory experiments and transitioned to scaling up processes in both pilot and production plants. This hands-on experience has equipped him with a deep understanding of plant operations and the intricacies of pharmaceutical manufacturing.
In his current role, Francesco is instrumental in driving key projects that enhance operational efficiency and product quality within the Eyecare sector. His expertise in supply chain management and process optimization allows him to lead change initiatives that streamline operations and improve overall productivity. Francesco is adept at problem-solving, utilizing his analytical background to tackle complex challenges that arise in the fast-paced pharmaceutical landscape. He is also skilled in budget planning and forecasting, ensuring that projects are not only innovative but also financially viable.
Francesco’s commitment to excellence is further reflected in his ability to launch new products successfully, navigating the regulatory landscape with precision. His strong social networking skills enable him to foster collaborations across departments and with external partners, enhancing AbbVie’s position in the competitive market. As a leader, Francesco inspires his team to embrace a culture of continuous improvement, driving the Eyecare division towards greater achievements in patient care and therapeutic innovation.
